Skip to main content
dryadpublic

Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension

ShareScore

36/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
4
Harmonization
12
Access
12
Reuse readiness
0
Engagement
8